Objective To compare the clinical and radiographic outcomes in patients with rheumatoid
arthritis (RA) who received monotherapy with either etanercept or methotrexate (MTX) for 2 …

Objective. To determine whether sulfasalazine (SSZ) at a dosage of 2,000 mg/day is effective
for the treatment of active psoriatic arthritis (PsA) resistant to nonsteroidal antiinflammatory …

Background: Disease-modifying antirheumatic drugs may confer greater benefits when
combined with the antimetabolite methotrexate. Objective: To evaluate the efficacy and safety of …

Objective To examine the degree to which shared risk factors explain the relationship of
periodontitis (PD) to rheumatoid arthritis (RA) and to determine the associations of PD and …

… The study was supported in part by an unrestricted grant from Lederle Laboratories (Pearl
River, New Jersey) to Albany Medical College, which disbursed the funds to the participating …

Objective. To describe the clinical, laboratory, radiologic, and histopathologic features of
methotrexate (MTX)‐induced lung injury in a combined cohort of selected patients with …

Objective Three 6–12‐month, double‐blind, randomized, controlled trials have shown
leflunomide (LEF; 20 mg/day, loading dose 100 mg × 3 days) to be effective and safe for the …

Objective. To determine whether sulfasalazine (SSZ) at a dosage of 2,000 mg/day is
effective for the treatment of active ankylosing spondylitis (AS) that is not controlled with …

Objective The co‐occurrence of rheumatoid factor (RF) and anti–citrullinated protein antibody
(ACPA) positivity in rheumatoid arthritis (RA) is well described. However, the mechanisms …

Methotrexate therapy has been effective in the treatment of RA with short term experience
suggesting little serious adverse reactions. Our review of 168 patients receiving methotrexate …